A population-based study using National Health and Nutrition Examination Survey data from 2007 to 2018 found that elevated inflammatory indicators derived from routine complete blood cell counts are independently associated with higher all-cause mortality in patients with rheumatoid arthritis. The study included 1314 patients with rheumatoid arthritis and found that elevated levels of systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR), and monocyte-to-lymphocyte ratio (MLR) were associated with increased mortality, suggesting that these blood cell count–derived markers may serve as accessible prognostic indicators for long-term mortality risk in rheumatoid arthritis.

Source: Frontiers in Medicine